- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x COA: COENZYME A(Non-covalent)
- 6 x 5LR: 5-(4-chlorophenyl)-~{N}-[3-(3,4-dihydro-1~{H}-isoquinolin-2-yl)propyl]-4-methyl-1,1-bis(oxidanylidene)-1,2-thiazol-3-amine(Non-covalent)
5LR.2: 16 residues within 4Å:- Chain A: F.44, D.46, F.47, I.48, A.53, W.56, R.57, V.60, L.83, M.85, S.103, F.104, V.105, H.139, E.421, F.422
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:F.44, A:F.44, A:A.53, A:W.56, A:W.56, A:F.104, A:V.105
- Hydrogen bonds: A:I.48, A:F.104
- Salt bridges: A:D.46, A:E.421
5LR.5: 16 residues within 4Å:- Chain B: F.44, D.46, F.47, I.48, A.53, W.56, R.57, V.60, L.83, M.85, S.103, F.104, V.105, H.139, E.421, F.422
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:F.44, B:F.44, B:A.53, B:W.56, B:W.56, B:F.104, B:V.105
- Hydrogen bonds: B:I.48, B:F.104
- Salt bridges: B:D.46, B:E.421
5LR.8: 16 residues within 4Å:- Chain C: F.44, D.46, F.47, I.48, A.53, W.56, R.57, V.60, L.83, M.85, S.103, F.104, V.105, H.139, E.421, F.422
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:F.44, C:F.44, C:A.53, C:W.56, C:W.56, C:F.104, C:V.105
- Hydrogen bonds: C:I.48, C:F.104
- Salt bridges: C:D.46, C:E.421
5LR.11: 16 residues within 4Å:- Chain D: F.44, D.46, F.47, I.48, A.53, W.56, R.57, V.60, L.83, M.85, S.103, F.104, V.105, H.139, E.421, F.422
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:F.44, D:F.44, D:A.53, D:W.56, D:W.56, D:F.104, D:V.105
- Hydrogen bonds: D:I.48, D:F.104
- Salt bridges: D:D.46, D:E.421
5LR.14: 16 residues within 4Å:- Chain E: F.44, D.46, F.47, I.48, A.53, W.56, R.57, V.60, L.83, M.85, S.103, F.104, V.105, H.139, E.421, F.422
11 PLIP interactions:11 interactions with chain E- Hydrophobic interactions: E:F.44, E:F.44, E:A.53, E:W.56, E:W.56, E:F.104, E:V.105
- Hydrogen bonds: E:I.48, E:F.104
- Salt bridges: E:D.46, E:E.421
5LR.17: 16 residues within 4Å:- Chain F: F.44, D.46, F.47, I.48, A.53, W.56, R.57, V.60, L.83, M.85, S.103, F.104, V.105, H.139, E.421, F.422
11 PLIP interactions:11 interactions with chain F- Hydrophobic interactions: F:F.44, F:F.44, F:A.53, F:W.56, F:W.56, F:F.104, F:V.105
- Hydrogen bonds: F:I.48, F:F.104
- Salt bridges: F:D.46, F:E.421
- 6 x CL: CHLORIDE ION(Non-functional Binders)
CL.3: 4 residues within 4Å:- Chain A: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.6: 4 residues within 4Å:- Chain B: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.9: 4 residues within 4Å:- Chain C: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.12: 4 residues within 4Å:- Chain D: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.15: 4 residues within 4Å:- Chain E: T.289, H.290, Q.417, T.418
Ligand excluded by PLIPCL.18: 4 residues within 4Å:- Chain F: T.289, H.290, Q.417, T.418
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Willby, M.J. et al., Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis. Acs Chem.Biol. (2016)
- Release Date
- 2016-03-30
- Peptides
- Enhanced intracellular survival protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x COA: COENZYME A(Non-covalent)
- 6 x 5LR: 5-(4-chlorophenyl)-~{N}-[3-(3,4-dihydro-1~{H}-isoquinolin-2-yl)propyl]-4-methyl-1,1-bis(oxidanylidene)-1,2-thiazol-3-amine(Non-covalent)
- 6 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Willby, M.J. et al., Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis. Acs Chem.Biol. (2016)
- Release Date
- 2016-03-30
- Peptides
- Enhanced intracellular survival protein: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A